noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Celcuity Inc.

A randomized phase II non comparative study of PF 04691502 and[...]
Celcuity Inc.

Subgroup of ovarian cancer patients with hyperactive RAS network[...]
Celcuity Inc.

Subgroup of HER2-negative breast cancer patients with hyperactive RAS[...]

Healthcare

Celcuity Inc.

03/04/2022 | Press release | Archived content

First in human study of PF 05212384 (PKI 587), a small molecule, intravenous, dual inhibitor of PI3K and mTOR in patients with advanced cancer. Clin Cancer Res; 21(8) April 15,[...]

Sharing and Personal Tools

Please select the service you want to use: